Immuron ceo steven lydeamore presented at ausbioinvest

Melbourne, australia, oct. 30, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company, is pleased to advise our chief executive officer, steven lydeamore, presented at ausbioinvest 2023 on monday, october 30th in the 9.40am – 10.35am session (aest) at the park hyatt, melbourne, australia.
IMRN Ratings Summary
IMRN Quant Ranking